Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study.
Saved in:
| Title: | Impact of prior chemotherapy on nanoliposomal irinotecan with fluorouracil and folinic acid for unresectable pancreatic cancer: a retrospective analysis of data from the multicenter NAPOLEON-2 study. |
|---|---|
| Authors: | Koike T; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan., Kawaguchi Y; Department of Gastroenterology, Asakura Medical Association Hospital, Asakura-shi, Fukuoka, Japan., Shimokawa M; Clinical Research Institute, National Kyushu Cancer Center, Fukuoka-shi, Fukuoka, Japan.; Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Ube-shi, Yamaguchi, Japan., Otsuka T; Department of Internal Medicine, Minato Medical Clinic, Fukuoka-shi, Fukuoka, Japan., Furukawa K; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan., Shinohara Y; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan., Shimokawa H; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan.; Department of Medical Oncology, Hamanomachi Hospital, Fukuoka-shi, Fukuoka, Japan., Yoshihiro T; Department of Hematology and Oncology, Japan Community Healthcare Organization Kyushu Hospital, Kitakyushu-shi, Fukuoka, Japan., Shibuki T; Division of Drug and Diagnostic Development Promotion, Department for the Promotion of Drug and Diagnostic Development, Translational Research Support Office, National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan., Nakazawa J; Department of Medical Oncology, Kagoshima City Hospital, Kagoshima-shi, Kagoshima, Japan., Arima S; Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima-shi, Kagoshima, Japan., Miwa K; Multidisciplinary Treatment Cancer Center, Kurume University Hospital, Kurume-shi, Fukuoka, Japan., Koga F; Department of Hepatobiliary and Pancreatology, Saga Medical Center Koseikan, Saga-shi, Saga, Japan., Ueda Y; Department of Hematology and Oncology, Japanese Red Cross Kumamoto Hospital, Kumamoto-shi, Kumamoto, Japan., Kubotsu Y; Department of Internal Medicine, Karatsu Red Cross Hospital, Karatsu-shi, Saga, Japan., Takeshita S; Department of Gastroenterology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki-shi, Nagasaki, Japan., Nishikawa K; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu-shi, Oita, Japan., Komori A; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu-shi, Oita, Japan.; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama-shi, Ehime, Japan., Otsu S; Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Yufu-shi, Oita, Japan., Hosokawa A; Department of Clinical Oncology, University of Miyazaki Hospital, Miyazaki-shi, Miyazaki, Japan., Sakai T; Department of Medical Oncology, NHO Kumamoto Medical Center, Kumamoto-shi, Kumamoto, Japan., Oda H; Division of Integrative Medical Oncology, Saiseikai Kumamoto Hospital, Kumamoto-shi, Kumamoto, Japan., Kawahira M; Department of Gastroenterology, Kagoshima Kouseiren Hospital, Kagoshima-shi, Kagoshima, Japan., Arita S; Department of Chemotherapy, Miyazaki Prefectural Miyazaki Hospital, Miyazaki-shi, Miyazaki, Japan., Honda T; Department of Gastroenterology and Hepatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki-shi, Nagasaki, Japan., Taguchi H; Department of Gastroenterology, Izumi General Medical Center, Izumi-shi, Kagoshima, Japan.; Department of Gastroenterology, Kagoshima City Hospital, Kagoshima-shi, Kagoshima, Japan., Tsuneyoshi K; Department of Gastroenterology, Izumi General Medical Center, Izumi-shi, Kagoshima, Japan., Fujita T; Department of Gastroenterology, Saiseikai Sendai Hospital, Satsumasendai-shi, Kagoshima, Japan., Sakae T; Department of Gastroenterology, Saiseikai Sendai Hospital, Satsumasendai-shi, Kagoshima, Japan., Shirakawa T; Clinical Hematology Oncology Treatment Study Group, 1-14-6 Muromi-gaoka, Nishi-ku, Fukuoka-shi, Fukuoka 819-0030, Japan.; Department of Medical Checkup Center, Eikoh Hospital, 3-8-15 Befu-nishi, Shime-machi, Kasuya-gun, Fukuoka 811-2232, Japan., Mizuta T; Department of Internal Medicine, Fujikawa Hospital, Saga-shi, Saga, Japan., Mitsugi K; Department of Medical Oncology, Sasebo Kyosai Hospital, Sasebo-shi, Nagasaki, Japan. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Nov 18; Vol. 17, pp. 17588359251393156. Date of Electronic Publication: 2025 Nov 18 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359251393156 |
